VREX vs MLAB

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

VREX

58.6
AI Score
VS
VREX Wins

MLAB

45.5
AI Score

Investment Advisor Scores

VREX

59score
Recommendation
HOLD

MLAB

46score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric VREX MLAB Winner
Revenue 636.10M 122.47M VREX
Net Income 9.90M 7.17M VREX
Gross Margin 34.4% 64.4% MLAB
Net Margin 1.6% 5.9% MLAB
Operating Income 52.60M 15.42M VREX
ROE 2.0% 3.7% MLAB
ROA 0.9% 1.8% MLAB
Total Assets 1.10B 407.74M VREX
Cash 99.20M 22.31M VREX
Debt/Equity 0.70 0.33 MLAB
Current Ratio 3.38 1.90 VREX
Free Cash Flow -22.50M 17.89M MLAB

Relative Price Performance (Last 90 Days)

VREX 1M: -0.4% · 3M: -0.6% MLAB 1M: +9.1% · 3M: +23.0%

Current Technical Phase

VREX

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 54

RSI (14): 53.6 · Price: $18.39

MLAB

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (3.9% over 20 days), RSI 62

RSI (14): 61.9 · Price: $139.21

Fundamentals Snapshot

Metric VREX MLAB
Market Cap — —
Forward P/E 17.2 25.8
Trailing P/E 34.8 118.0
Revenue (TTM) — —
Revenue Growth 0.0% 0.0%
Gross Margin 0.3% 0.6%
Operating Margin 0.1% 0.1%
EPS 0.53 1.16
Dividend Yield — 0.01%

Frequently Asked Questions

Based on our detailed analysis, VREX is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.